Business Standard

Glenmark Life Sciences

Glenmark Life, Pharma in focus: Shares fall up to 4% amid stake sale buzz

Shares of Glenmark Pharmaceuticals slipped 1.60 per cent at Rs 1357.30 per share on the Bombay Stock Exchange (BSE) in Thursday's early morning trade

Glenmark Life, Pharma in focus: Shares fall up to 4% amid stake sale buzz
Updated On : 11 Jul 2024 | 11:31 AM IST

Glenmark Pharmaceuticals to sell 7.84% stake in Glenmark Life Sciences

The specific price and date of the offer for sale will likely be announced in the future

Glenmark Pharmaceuticals to sell 7.84% stake in Glenmark Life Sciences
Updated On : 10 Jul 2024 | 5:31 PM IST

Pharma shares shine; Dr Reddy's, FDC, Glenmark, Suven trade at record highs

Shares of Wockhardt hit a multi-year high of Rs 943.20, zooming 65 per cent in past nine trading days.

Pharma shares shine; Dr Reddy's, FDC, Glenmark, Suven trade at record highs
Updated On : 03 Jul 2024 | 3:01 PM IST

Glenmark Life Sciences Q4 results: Profit dips 33.62% to Rs 97.93 crore

For the fiscal year 2023-2024, Glenmark Life Sciences reported revenue from operations of Rs 2,283.2 crore, marking a growth of 5.6 per cent year-over-year (Y-o-Y)

Glenmark Life Sciences Q4 results: Profit dips 33.62% to Rs 97.93 crore
Updated On : 25 Apr 2024 | 9:08 PM IST

Glenmark Life Sciences Q4 results: Profit down 33% at Rs 97.9 crore

Revenue from its API business, its biggest, fell 8.6% in the fourth quarter, leading to a nearly 14% fall in its total revenue

Glenmark Life Sciences Q4 results: Profit down 33% at Rs 97.9 crore
Updated On : 25 Apr 2024 | 3:43 PM IST

Nirma completes acquisition of 75% stake in Glenmark Life Sciences

The acquisition strengthens Nirma's presence in the pharmaceuticals and life sciences sector

Nirma completes acquisition of 75% stake in Glenmark Life Sciences
Updated On : 12 Mar 2024 | 10:14 PM IST

Glenn Saldanha announced resignation as chairman of Glenmark Life Sciences

Glenmark Life Sciences Ltd on Wednesday said its Chairman Glenn Saldanha and non-executive director VS Mani have resigned following change in ownership of the company. Independent director Sridhar Gorthi has also tendered resignation, along with Saldanha and Mani, with effect from close of business hours on March 6, 2024, the company said in a regulatory filing. In his resignation letter shared on BSE by the company, Saldanha said his stepping down from the board and as chairman of the company is "pursuant to the transfer of ownership of the company by Glenmark Pharmaceuticals to Nirma Ltd". He is also stepping down as a member of the nomination and remuneration committee and operations committee of Glenmark Life Sciences. In September last year, Nirma Ltd had agreed to acquire 75 per cent stake in Glenmark Life Sciences for Rs 5,651.5 crore from Glenmark Pharmaceuticals. Mani also cited a similar reason for his resignation. On the other hand, Gorthi cited increasing professiona

Glenn Saldanha announced resignation as chairman of Glenmark Life Sciences
Updated On : 06 Mar 2024 | 11:46 PM IST

Nirma's open offer to buy more stake in Glenmark Life to start on Feb 15

Nirma Ltd will kick off a Rs 1,343.05-crore open offer next week to acquire an additional 17.33 per cent stake from public shareholders of Glenmark Life Sciences Ltd, according to a regulatory filing. The development follows Nirma's deal to acquire 75 per cent stake in Glenmark Life Sciences for Rs 5,651.5 crore agreed in September last year. The open offer is being made to the public shareholders to acquire up to 2.13 crore equity shares representing 17.33 per cent of the voting share capital at an offer price of Rs 631.20 per share aggregating to a total consideration of up to Rs 1,343.05 crore, said the letter of offer by Nirma shared on BSE by Glenmark Life Sciences. The offer shares include the entire public shareholding in the target company (over 2.1 crore shares) and 2.63 lakh vested ESOPs, it added. The opening date (commencement of the tendering period) for the open offer has been fixed on February 15, 2024 and will close on February 29, 2024, as per the letter of offer,

Nirma's open offer to buy more stake in Glenmark Life to start on Feb 15
Updated On : 09 Feb 2024 | 7:21 PM IST

Glenmark Life Sciences Q3 profit rises to Rs 119 cr, API biz up 6.4%

The Mumbai-based company, which detergent maker Nirma is in the process of taking over, said its profit rose to 1.19 billion rupees ($14.32 million) in the quarter ended Dec. 31

Glenmark Life Sciences Q3 profit rises to Rs 119 cr, API biz up 6.4%
Updated On : 23 Jan 2024 | 7:32 PM IST

Glenmark Life Sciences Q2 results: PAT rises 11%, revenue up 16.9%

Generic API revenues increased by 19.7 percent this quarter due to growth in US, LATAM and Europe regulated markets

Glenmark Life Sciences Q2 results: PAT rises 11%, revenue up 16.9%
Updated On : 20 Oct 2023 | 5:01 PM IST

Glenmark Life Sciences posts Q2 results, profit up on back of API boost

The Mumbai-based drugmaker said its profit rose to Rs 113 crore ($14.3 million) for the quarter ended Sept. 30, from Rs 107 crore year earlier

Glenmark Life Sciences posts Q2 results, profit up on back of API boost
Updated On : 20 Oct 2023 | 2:37 PM IST

Glenmark Pharma launches triple-combination drug for Type 2 Diabetes

Medication will be sold under the brand name Zita DM, will be priced at Rs 14 per tablet

Glenmark Pharma launches triple-combination drug for Type 2 Diabetes
Updated On : 18 Oct 2023 | 10:39 PM IST

Nirma to tap into own funds, debt to buy Glenmark Life Sciences

The company had earlier informed banks that it would raise Rs 5,000 crore to Rs 7,000 crore in the current financial year for the acquisition

Nirma to tap into own funds, debt to buy Glenmark Life Sciences
Updated On : 24 Sep 2023 | 10:31 PM IST

Glenmark Pharma's life sciences arm deal may hit FY25 revenue estimates

But it will have additional cash to recalibrate its innovative pipeline

Glenmark Pharma's life sciences arm deal may hit FY25 revenue estimates
Updated On : 22 Sep 2023 | 10:49 PM IST

Glenmark Pharma slips 5% on inking deal to sell 75% stake GLS to Nirma

The company announced that it will sell 75 per cent stake in Glenmark Life Sciences (GLS) to Nirma for Rs 5,652 crore at Rs 615 per share.

Glenmark Pharma slips 5% on inking deal to sell 75% stake GLS to Nirma
Updated On : 22 Sep 2023 | 10:07 AM IST

Stocks to Watch on Sept 22: JSW Steel, Glenmark Life, Samhi, Zaggle, TaMo

Stocks to Watch today, September 22, 2023: Glenmark Pharmaceuticals Board has approved the divestment of a 75 per cent stake in its subsidiary Glenmark Life Sciences to Nirma for Rs 5,651 crore

Stocks to Watch on Sept 22: JSW Steel, Glenmark Life, Samhi, Zaggle, TaMo
Updated On : 22 Sep 2023 | 8:18 AM IST

Glenmark Pharma to sell 75% stake in GLS to Nirma for Rs 5,651 crore

Deal size estimated to be Rs 5,651 crore, valuing API arm at Rs 7,535 crore

Glenmark Pharma to sell 75% stake in GLS to Nirma for Rs 5,651 crore
Updated On : 21 Sep 2023 | 11:23 PM IST
Updated On : 01 Aug 2023 | 10:44 PM IST

Nirma emerges as frontrunner for Glenmark's API arm as bid deadline ends

Nirma Ltd and Sekhmet Pharmaventures were among the shortlisted bidders for a controlling stake in GLS

Nirma emerges as frontrunner for Glenmark's API arm as bid deadline ends
Updated On : 31 Jul 2023 | 1:16 PM IST

Nirma looks to raise up to Rs 7,000 crore to fund buys and expansion

The unlisted company posted revenues to the tune of Rs 11,403 crore in fiscal 2023

Nirma looks to raise up to Rs 7,000 crore to fund buys and expansion
Updated On : 27 Jul 2023 | 10:30 PM IST